The detailed operation standards for the Price-Volume Agreement negotiations will change drastically from May. The reduction rate will be applied differently depending on the amount of each drug’s insurance claims, and products with annual claims of less than KRWk 3 billion will be excluded. In addition, the discount rate of drugs that have been subject to negotiations more than 3 times will be reduced.

The National Health Insurance Service (NHIS) announced on April 29 that it will completely reorganize the 'Detailed Operating Guidelines for Price-Volume Agreement Negotiations’ from May.

The PVA system adjusts drug prices through negotiation for drugs whose costs increased by a